What is Perspective Therapeutics's notes payable current?

Perspective Therapeutics (CATX) reported notes payable current of $56K in Q1 2026.

How has Perspective Therapeutics's notes payable current changed year-over-year?

Perspective Therapeutics's notes payable current increased by 5.7% year-over-year, from $53K to $56K.

What is the long-term trend for Perspective Therapeutics's notes payable current?

Over 2 years (2023 to 2025), Perspective Therapeutics's notes payable current has grown at a 6.9% compound annual growth rate (CAGR), from $49K to $56K.

Perspective Therapeutics CATX Notes Payable Current

Notes Payable Current at other companies

CarvanaCVNA

$229M-25.6%

Galaxy Digital Inc. Class A Common StockGLXY

$432.73M—

Old Second BancorpOSBC

$14.84M—

Andersen Group ANDG

$57.47M—

Willdan GroupWLDN

$2.5M0.0%

EnvelaELA

$7.69M+126%

Other financials

Income statement

See full

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

See full

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

See full

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

See full

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

See full

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

See full

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NotesPayableCurrent.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's notes payable current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Perspective Therapeutics's notes payable current?: Perspective Therapeutics (CATX) reported notes payable current of $56K in Q1 2026.
How has Perspective Therapeutics's notes payable current changed year-over-year?: Perspective Therapeutics's notes payable current increased by 5.7% year-over-year, from $53K to $56K.
What is the long-term trend for Perspective Therapeutics's notes payable current?: Over 2 years (2023 to 2025), Perspective Therapeutics's notes payable current has grown at a 6.9% compound annual growth rate (CAGR), from $49K to $56K.